Blogs about: Vanilloid
Featured Blog
Glenmark/Lilly suspend trials with TRPV1 antagonist GRC 6211 in OA
Glenmark and Lilly have announced they have suspended further clinical development for TRPV1 antagonist GRC 6211 in Osteoarthritis pain.… more →
GPCR News
Glenmark/Lilly suspend trials with TRPV1 antagonist GRC 6211 in OA
crimsoncanary wrote 1 year ago: Glenmark and Lilly have announced they have suspended further clinical development for TRPV1 antagon … more →
Glenmark/Lilly suspend trials with TRPV1 antagonist GRC 6211 in OA
crimsoncanary wrote 1 year ago: Glenmark and Lilly have announced they have suspended further clinical development for TRPV1 antagon … more →
NeurogesX Submit NDA for NGX-4010 for Treatment of Postherpetic Neuralgia (PHN)
crimsoncanary wrote 1 year ago: NeurogesX have submitted a new drug application (NDA) with the U.S. FDAS for NGX-4010 Dermal Capsaic … more →
Evotec/Pfizer initiate Phase I trial of VR1 antagonist
crimsoncanary wrote 1 year ago: Evotec AG have announced the initiation of a Phase I clinical trial of a small molecule VR1 (vanillo … more →
Evotec/Pfizer initiate Phase I trial of VR1 antagonist
crimsoncanary wrote 1 year ago: Evotec AG have announced the initiation of a Phase I clinical trial of a small molecule VR1 (vanillo … more →
Anesiva insitate Phase II trual of Adlea in Arthroscopic Shoulder Surgery
crimsoncanary wrote 1 year ago: Anesiva have begun a Phase II clinical trial of Adlea, the company’s long-acting capsaicin product i … more →
Anesiva insitate Phase II trual of Adlea in Arthroscopic Shoulder Surgery
crimsoncanary wrote 1 year ago: Anesiva have begun a Phase II clinical trial of Adlea, the company’s long-acting capsaicin pro … more →
NeurogesX Initiate Phase I of NGX-1998 Capsaicin Liquid Formulation
crimsoncanary wrote 1 year ago: NeurogesX has initiated a Phase 1 clinical trial of NGX-1998, a high-concentration, capsaicin-based … more →
NeurogesX Initiate Phase I of NGX-1998 Capsaicin Liquid Formulation
crimsoncanary wrote 1 year ago: NeurogesX has initiated a Phase 1 clinical trial of NGX-1998, a high-concentration, capsaicin-based … more →
Resiniferatoxin inhibits Ca2+ channels independent of TRPV1
crimsoncanary wrote 1 year ago: Researchers from Brigham & Women’s Hospital have shown that resiniferatoxin blocks voltage … more →
NeurogesX publish Phase III data on NGX-4010 in HIV neuropathy
crimsoncanary wrote 1 year ago: NeurogesX have published Phase 3 data of its lead capsaicin product NGX-4010 in Neurology. The trial … more →
Phase II trials of Adlea in post orthopedic surgery pain to take place in South Korea
crimsoncanary wrote 1 year ago: Anesiva to begin Phase II trial of Capsaicin drug Adlea for use in the treatment of post orthopedic … more →
Phase II trials of Adlea in post orthopedic surgery pain to take place in South Korea
crimsoncanary wrote 1 year ago: Anesiva to begin Phase II trial of Capsaicin drug Adlea for use in the treatment of post orthopedic … more →
NeurogesX submit IND for liquid formulation of Capsaicin, NGX-1998
crimsoncanary wrote 1 year ago: NeurogesX have submitted an IND for the liquid formulation of Capsaicin, NGX-1998 for the treatment … more →
NeurogesX submit IND for liquid formulation of Capsaicin, NGX-1998
crimsoncanary wrote 1 year ago: NeurogesX have submitted an IND for the liquid formulation of Capsaicin, NGX-1998 for the treatment … more →
Vanilloid Receptor (TRPV) agonists and antagonists in development
— 1 comment
crimsoncanary wrote 2 years ago: Attached is a link to the latest competitor information I’ve pulled together on Vanilloid rece … more →
